Currently, the established prognostic factors for prostate cancer (PC) are the TNM staging of the tumor (primary tumor, regional lymph nodes and distant metastases) of the AJCC (American Joint Committee on Cancer) (8), status of surgical margins, level of serum PSA and Gleason score (2). The gene discussed is KLK3; the disease is prostate carcinoma.